Fatigue: FDA reporting patterns
766,540 FDA FAERS reports mention Fatigue. 400,869 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 39,717 reports
- Etanercept: 30,011 reports
- Lenalidomide: 26,544 reports
- Methotrexate: 21,058 reports
- Natalizumab: 19,191 reports
- Infliximab: 18,442 reports
- Rituximab: 17,569 reports
- Prednisone: 15,696 reports
- Palbociclib: 15,436 reports
- Tocilizumab: 14,560 reports
- Tofacitinib: 14,089 reports
- Abatacept: 13,914 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.